Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients

Nephrology

Volumn 11, Issue 6, 2006, Pages 506-509

  Tsirpanlis, George ^a,d   Chatzipanagiotou, Stylianos ^b   Boufidou, Fotini ^b   Kordinas, Vasileios ^b   Zoga, Margarita ^b   Alevyzaki, Fotini ^a   Stamatelou, Kyriaki ^c   Frangou, Eleni ^a   Savva, Lefkothea ^a   Nicolaou, Chrysoula ^b  

^a KAT HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c Blue Cross Hospital   (Greece)

^d NONE   (Greece)

Author keywords

Cytokine; Inflammation; Oxidative stress; Renal failure; Telomere; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 10; OXIDIZED LOW DENSITY LIPOPROTEIN; TELOMERASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; INFLAMMATION; MULTIPLE LINEAR REGRESSION ANALYSIS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ATHEROSCLEROSIS; CELL AGING; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; TELOMERASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845639997     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00697.x     Document Type: Article

References (18)

1. Ben-Porath I, Weinberg RA. When cells get stressed: An integrative view of cellular senescence. J. Clin. Invest. 2004; 113: 8-13.
2. Blackburn EH. Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005; 579: 859-62.
3. Roth A, Yssel H, Pene J et al. Telomerase levels control the lifespan of human T lymphocytes. Blood 2003; 102: 849-57.
4. Tsirpanlis G, Chatzipanagiotou S, Boufidou F et al. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am. J. Nephrol. 2006; 26: 91-6.
5. Tsirpanlis G, Bagos P, Ioannou D et al. Exploring inflammation in hemodialysis patients: Persistent and superimposed inflammation. Kidney Blood Press. Res. 2004; 27: 63-70.
6. Tsirpanlis G, Boufidou F, Manganas S et al. Treatment with fluvastatin rapidly modulates, via different pathways, and in dependence on the baseline level, inflammation in hemodialysis patients. Blood Purif. 2004; 22: 518-24.
7. Tsirpanlis G, Chatzipanagiotou S, Ioannidis A et al. Serum and peripheral blood mononuclear cells infectious burden: Correlation to inflammation and atherosclerosis in haemodialysis patients. Nephrology 2005; 10: 256-63.
8. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-16.
9. Borras C, Esteve JM, Vina JR et al. Glutathione regulates telomerase activity in 3T3 fibroblasts. J. Biol. Chem. 2004; 279: 34 332-5.
10. Ujhelyi L, Balla G, Jeney V et al. Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int. 2006; 69: 144-51.
11. Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 2001; 493: 21-5.
12. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin. Exp. Pharmacol. Physiol. 2004; 31: 407-13.
13. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 842-6.
14. Epel ES, Lin J, Wilhem FH et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology 2005; 10.1016/j.psyneuen.2005.08.011.
15. Tsirpanlis G. The pattern of inflammation and a potential new clinical meaning and usefulness of C-reactive protein in end-stage renal failure patients. Kidney Blood Press. Res. 2005; 28: 55-61.
16. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia - The good, the bad, and the ugly. Kidney Int. 2005; 67: 1216-33.
17. Ramirez R, Carracedo J, Soriano S et al. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am. J. Kidney Dis. 2005; 45: 353-9.
18. Tsirpanlis G, Bagos P, Ioannou D et al. The variability and accurate assessment of microinflammation in hemodialysis patients. Nephrol. Dial. Transplant. 2004; 19: 150-57.